Managing Clinical and
Cost Outcomes in Multiple Sclerosis:
Utilizing Data to Make Informed Decisions in Managed Care
A continuing medical
education activity sponsored by NAMCP and AAMCN
This webinar series will provide critical updates on the advances in
the management of MS
These are archives of live webinars held between November 19 to
December 1, 2020.
If you participated in any of the live webinars, you are not
claim credit from the archive of that webinar.
By clicking on each of the titles, you will be able to participate
in each part.
It is not required that you participate in all 3 or in order.
This activity is valid from January 1, 2021 to January 1, 2023
series is supported by educational grants from
Biogen, Novartis Pharmaceuticals Corporation and Sanofi Genzyme
This activity is intended for healthcare professionals practicing in managed
Instructions for CME/NCPD: Complete the pre-test,
listen to the audio and view the slides, complete the post test, complete the
evaluation form and hit submit. You will be asked to enter your name and email
address on the pre-test, evaluation and post-test. If you close your internet
browser without completing the post test, you will have ONE more opportunity to
complete. A score of 70% must be achieved on the post test to receive continuing
education credits. If you do not pass the post test after two attempts, you will
not be eligible to try again. Once you complete the evaluation form and score
70% or higher on your post test, you will automatically be given your
Multiple Sclerosis (MS) is a chronic progressive
disease. It is the most common neurological cause of disability among young
adults, with a prevalence of approximately one million cases throughout the
United States. Although there is still no cure for MS, many advances in MS
treatment have arrived in recent years, allowing patients to manage these
symptoms and improve their quality of life. Effective and timely treatment of MS
can greatly improve the quality of life in MS patients. With the advancement and
complexity of different treatment options, including therapies that have
recently become available, managed care professionals are being challenged to
make informed decisions in their organizations and provide the correct treatment
options that are available to patients.